Selank

What Is Selank?

Selank is a synthetic heptapeptide derived from tuftsin, a naturally occurring tetrapeptide fragment associated with immune-system signaling pathways. Developed as a modified analogue of tuftsin, Selank incorporates additional amino acid residues that improve stability in experimental systems and support its use as a research tool in studies involving peptide-mediated signaling and regulatory biology.

Because of its structural relationship to tuftsin, Selank has been investigated across a range of experimental models examining neuropeptide signaling, neuroendocrine communication, and regulatory peptide activity. Researchers use Selank to explore how short peptides may participate in complex signaling networks and influence communication among interconnected biological systems.

In the scientific literature, Selank is studied in vitro and in animal models involving neuropeptide biology, neuronal signaling pathways, and broader neuroregulatory research. Investigations have examined its potential interactions with signaling systems associated with GABAergic and monoaminergic pathways, although the precise mechanisms underlying these observations remain an active area of research.

Unlike receptor-selective compounds that act through a single well-defined target, Selank is generally investigated as a regulatory peptide with potential involvement across multiple signaling networks. This systems-level research focus has made it a commonly referenced compound in studies of neuropeptide-mediated communication and peptide-based regulatory processes.

Most available findings on Selank originate from preclinical research, including in vitro studies and animal models. As such, current understanding should be interpreted strictly within a laboratory and research framework and should not be extrapolated to human or veterinary applications.

Bluum Peptides supplies Selank as a high-purity, lyophilized research peptide manufactured using controlled solid-phase peptide synthesis (SPPS) and HPLC purification to achieve purity levels exceeding 99%. Each batch also undergoes independent third-party analytical verification to confirm identity and purity, with lot-specific Certificates of Analysis (COAs) available for review.

Selank is supplied strictly for research use only and is not intended for human consumption, therapeutic use, diagnostic use, or veterinary applications.

Selank Mechanism of Action (Research Only)

Selank is a synthetic heptapeptide derived from tuftsin and studied for its potential involvement in neuropeptide signaling, neuroregulatory processes, and peptide-mediated communication pathways. Unlike receptor-selective compounds that act through a single well-characterized molecular target, Selank is generally investigated as a regulatory peptide whose activity may involve multiple interconnected signaling networks.

Note: current mechanistic understanding is derived primarily from in vitro experiments, animal models, and exploratory preclinical research. While several signaling pathways have been examined in association with Selank, its precise molecular mechanisms remain incompletely characterized and continue to be an active area of investigation.

Structural and Chemical Basis

Selank is a modified analogue of the endogenous peptide tuftsin, incorporating additional amino acid residues that improve stability in experimental systems relative to the parent tetrapeptide [1].

These structural characteristics have made Selank a useful research tool for investigating peptide-mediated signaling and regulatory biology. Researchers frequently use it to explore how short synthetic peptides interact with complex biological communication networks under controlled laboratory conditions.

Neuropeptide and Regulatory Signaling Research

One of the primary areas of Selank research involves neuropeptide-mediated signaling and broader neuroregulatory processes. Experimental studies have examined how Selank may interact with signaling systems involved in neuronal communication, pathway regulation, and network-level signaling behavior [1].

Because these pathways involve multiple overlapping biological processes, Selank is often studied as a systems-level regulatory peptide rather than a compound acting through a single defined receptor mechanism.

GABAergic-Associated Research Pathways

Selank has been investigated in experimental models examining signaling pathways associated with GABAergic systems and neuronal regulatory networks [2]. Researchers use these models to explore potential interactions between peptide-mediated signaling and pathways involved in neural communication and signal regulation.

However, current findings are largely preclinical, and the precise relationship between Selank and GABA-associated signaling mechanisms has not been fully characterized.

Monoaminergic and Neurochemical Signaling Studies

Additional research has examined Selank in relation to signaling systems associated with monoaminergic pathways and broader neurochemical communication networks [3]. Experimental investigations explore how regulatory peptides may interact with interconnected signaling systems involved in neuronal communication and pathway coordination.

These studies are intended to characterize signaling relationships within complex biological networks and should be interpreted within a research framework.

Immune-Neural Communication Research

Because Selank is structurally derived from tuftsin, researchers have also explored its role in experimental models involving immune-neural communication and peptide-mediated regulatory processes [4]. These investigations examine how signaling pathways associated with immune-system communication may intersect with broader neuroregulatory networks.

This area of research remains exploratory and is primarily focused on understanding systems-level signaling interactions rather than establishing specific biological outcomes.

Ongoing Mechanistic Investigation

Despite extensive research interest, Selank's precise molecular mechanisms remain incompletely understood. Contemporary research continues to investigate its potential involvement in neuropeptide signaling, neuroregulatory processes, and peptide-mediated communication networks using modern molecular biology and neurophysiology models.

Selank is supplied strictly for laboratory research use and serves as a research tool for investigating neuropeptide signaling, regulatory peptide biology, and neuroendocrine communication pathways. It is not intended for human consumption, therapeutic use, diagnostic use, or veterinary applications.

Selank Research Applications (Observations from Studies)

Selank has been investigated across preclinical and translational research settings as a tool for studying neuropeptide signaling, neuroregulatory processes, and peptide-mediated communication networks.

Note that the observations described below reflect experimental research findings and should be interpreted strictly within controlled laboratory environments. They do not represent established clinical outcomes or approved applications.

Neuropeptide and Neuroregulatory Signaling Research

One of the primary areas of Selank research involves neuropeptide-mediated signaling and broader neuroregulatory processes. Experimental studies use Selank to investigate how regulatory peptides interact with signaling networks involved in neuronal communication, pathway coordination, and systems-level signaling behavior [1].

Because Selank is not characterized by a single well-defined receptor mechanism, it is often studied as a model compound for exploring complex signaling relationships across multiple interconnected pathways.

GABAergic-Associated and Neurochemical Pathway Studies

Selank has been examined in experimental models involving signaling pathways associated with GABAergic systems and broader neurochemical communication networks [1][3]. Researchers use these studies to investigate potential relationships between peptide-mediated signaling and mechanisms involved in neuronal regulation and pathway coordination.

Current findings are largely preclinical and primarily used to characterize signaling behavior within controlled laboratory systems rather than establish specific biological outcomes.

Monoaminergic Signaling Research

Additional investigations have explored Selank in relation to signaling systems associated with monoaminergic pathways and neurochemical communication processes. Experimental models are used to examine how regulatory peptides may interact with interconnected signaling networks and influence pathway activity within complex biological systems.

This research contributes to a broader understanding of neuropeptide signaling and the potential role of regulatory peptides in coordinating communication among multiple signaling pathways.

Immune-Neural Communication Models

Because Selank is structurally derived from tuftsin, researchers have also investigated its use in experimental models involving immune-neural communication and peptide-mediated regulatory processes [4]. These studies examine how signaling pathways associated with immune-system communication may intersect with broader neuroregulatory networks.

Such models are useful for exploring systems-level interactions among multiple signaling domains and for investigating how peptide-mediated communication may function across interconnected biological systems.

Comparative Regulatory Peptide Research

Selank is frequently evaluated alongside other neuroactive and regulatory peptides in studies examining signaling characteristics, pathway interactions, and neuropeptide biology [6]. Researchers use these comparative models to better understand differences among peptide-signaling systems and to characterize the roles of regulatory peptides within complex communication networks.

This systems-oriented research focus continues to make Selank a useful tool for investigating neuropeptide signaling, neuroregulatory processes, and immune-neural communication pathways in experimental settings.

Bluum Peptides does not make or imply any medical or therapeutic claims regarding Selank. All findings referenced here are derived from experimental and non-clinical research settings. This compound is supplied strictly for laboratory research use and is not intended for clinical, diagnostic, therapeutic, veterinary, or human applications.

Selank vs Semax vs Tuftsin Comparison

Note: Selank is a modified tuftsin analog with improved experimental stability and broader signaling reach, which is why it appears in both neural and immune pathway studies, unlike tuftsin itself.

Selank Laboratory Safety & Handling (Research Use Only)

Selank is supplied as a lyophilized research peptide and should be handled in accordance with established laboratory procedures for peptide-based research materials. Appropriate handling, storage, and documentation practices help maintain material integrity and support consistency across experimental workflows.

As a synthetic peptide, Selank may be sensitive to environmental factors such as moisture, temperature fluctuations, excessive light exposure, and improper handling. Laboratory protocols should therefore be designed to minimize avoidable sources of degradation and experimental variability.

Laboratory Handling Considerations

Best-practice laboratory guidance includes:

• Follow institutional standard operating procedures (SOPs), chemical hygiene plans, and approved research protocols.

• Wear appropriate personal protective equipment (PPE), including gloves, laboratory coat, and eye protection.

• Conduct weighing, preparation, and handling procedures in controlled laboratory environments where appropriate to minimize contamination and environmental exposure.

• Handle lyophilized material carefully to avoid unnecessary particulate dispersion during transfer or preparation.

• Use suitable laboratory equipment, containers, and documentation practices to support consistency and traceability.

• Record lot numbers, preparation details, storage conditions, and associated laboratory documentation to support reproducibility.

• Follow institutional procedures for spill response, waste management, and incident reporting.

These practices are particularly important in neuropeptide signaling and regulatory peptide research, where material consistency can contribute to reliable experimental outcomes.

Storage and Stability Considerations

Appropriate storage conditions help preserve the integrity of lyophilized peptide materials during laboratory use.

• Store lyophilized material at approximately -4°F (-20°C), protected from light and moisture.

• For short-term handling, unopened material may be stored under refrigerated conditions (36–46°F / 2–8°C) when appropriate.

• Minimize repeated freeze-thaw cycles.

• Maintain consistent storage conditions across experiments to support reproducibility.

• Clearly label prepared materials with relevant concentration, preparation, and storage information.

• Inspect materials and associated documentation prior to use as part of routine laboratory quality-control procedures.

Careful storage and handling practices can help reduce avoidable sources of experimental variability and support consistency across research workflows.

Bluum Peptides supplies Selank strictly for research use only. This material is not intended for human consumption, therapeutic use, diagnostic use, or veterinary applications and should be handled exclusively within qualified laboratory settings.

Certificate of Analysis (COA) & Quality Assurance

Each Selank lot is accompanied by a third-party–verified Certificate of Analysis (COA) to support research reproducibility, batch traceability, and data integrity. COAs provide lot-specific analytical confirmation so researchers can document compound identity and quality before experimental use.

For research peptides such as Selank, COAs typically include: 

• Identity verification using analytical techniques such as mass spectrometry and/or comparable structural confirmation methods

• Purity and composition testing using HPLC or related chromatographic assays

• Relevant physicochemical data, such as solubility characteristics and stability-related notes

• Concentration verification where applicable

• Lot number and batch identifiers

• Testing date and analytical method references

Bluum Peptides works with independent analytical laboratories to provide objective third-party verification and consistent quality standards across production batches. These include Janoshik, BioRegen, Freedom Diagnostics, and other trusted analytical laboratories. 

Find the batch COA documents on the product page or request documentation from our support team. Researchers are encouraged to retain COAs and associated batch records to support audit readiness, reproducibility requirements, and independent verification under institutional research protocols.

Scientific References

1. Volkova A, Shadrina M, Kolomin T, Andreeva L, Limborska S, Myasoedov N, Slominsky P. Selank Administration Affects the Expression of Some Genes Involved in GABAergic Neurotransmission. Front Pharmacol. 2016 Feb 18;7:31.
https://pmc.ncbi.nlm.nih.gov/articles/PMC4757669/ 

2. Narkevich VB, Kudrin VS, Klodt PM, Pokrovskiĭ AA, Kozlovskaia MM, Maĭskiĭ AI, Raevskiĭ KS. [Effects of heptapeptide selank on the content of monoamines and their metabolites in the brain of BALB/C and C57Bl/6 mice: a comparative study]. Eksp Klin Farmakol. 2008 Sep-Oct;71(5):8-12. Russian. PMID: 19093364.
https://pubmed.ncbi.nlm.nih.gov/19093364/ 

3. Kolomin, T., Shadrina, M., Slominsky, P., Limborska, S., & Myasoedov, N. (2013). A new generation of drugs: Synthetic peptides based on natural regulatory peptides (pp. 223–252). Neuroscience & Medicine. https://pdfs.semanticscholar.org/2a11/334f12fff603f90a83ef1127e3192ca186b2.pdf 

4. Leonidovna YA, Aleksandrovna SM, Aleksandrovna TA, Aleksandrovna BO, Fedorovich MN, Aleksandrovna AL. The Influence of Selank on the Level of Cytokines Under the Conditions of "Social" Stress. Curr Rev Clin Exp Pharmacol. 2021;16(2):162-167.
https://pubmed.ncbi.nlm.nih.gov/32621722/ 

5. Kolik LG, Nadorova AV, Antipova TA, Kruglov SV, Kudrin VS, Durnev AD. Selank, Peptide Analogue of Tuftsin, Protects Against Ethanol-Induced Memory Impairment by Regulating of BDNF Content in the Hippocampus and Prefrontal Cortex in Rats. Bull Exp Biol Med. 2019 Sep;167(5):641-644.
https://pubmed.ncbi.nlm.nih.gov/31625062/